Just as being on the cover of Time magazine can predict doom, the introduction of a negative retail ETF may signal a turn in retail stocks. Why are Gap, Walmart and Kroger all up double digits in the last few months if retail is dead? Read More
Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities. She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.
She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.
Analyst Articles
An incredibly busy two weeks for Profit Catalyst Alert. With six new bullish options trades recommended, which ones are still good buys? Celgene gets hit due to sloppy results in a new indication for its cancer drug and more. Read More
A recent Morgan Stanley downgrade crushed the semiconductor group. The call for lower pricing seems premature and offers investors a terrific buying opportunity. Buy calls on these equipment manufacturers who are less exposed to chip pricing swings. Read More
Grocery stores haven't been able to increase prices for fear of losing customers. Will rising food costs, as seen in the recent PPI report, wreak havoc on their profits? Read More
Sell these January Target calls for a terrific gain. All three of the retail calls from my November recommendation delivered huge double-digit gains. With a pending January expiration and super high investor enthusiasm, I suggest booking this last gain. Read More
Sell Gap Inc. (NYSE: GPS). Gap's done a tremendous job at re-igniting sales growth but the current valuation fully reflects that success. Book the 48% gain and look for more trades with this name in the future. Read More
Drug stocks should be a healthy group in 2018. These three generate positive cash flow and have robust growth in their lead products. I expect pricing pressure from PBMs to muffle a bit as CVS and Aetna focus on getting their merger past the regulators. Read More
Corporate stock buybacks, mergers, and a limp IPO market are working together to boost stock prices. Find out how these mechanics send the forces of supply and demand out of balance and what it means for your portfolio. Read More
Stick with the Chemours Company as trends in its lead products remain strong. A downgrade by Goldman Sachs didn't sway my thesis on the stock. Smart Sand got a boost from another analyst and keep your eyes peeled for more trade alerts coming soon. Read More
United Parcel Service just put a surcharge on packages delivered during holiday crunch times. After years of swallowing the higher cost of e-commerce deliveries, transportation companies are getting smart about their expenses. Read More